HomeLatest Pharma-News

Latest Pharma-News

Latest Pharma-News

Novartis Pluvicto™ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer

admin - June 4, 2025

Latest Pharma-News

FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People

admin - June 4, 2025

Latest Pharma-News

J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin

admin - April 11, 2025

Latest Pharma-News

Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis

admin - April 9, 2025

Latest Pharma-News

Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy

admin - April 9, 2025

Latest Pharma-News

Bristol Myers Squibb Announces Positive Topline Result from Pivotal Phase 3 Trial Evaluating Opdivo® (nivolumab) plus Yervoy® (ipilimumab) vs. Chemotherapy in Previously Untreated Malignant...

admin - April 21, 2020 0

Latest Pharma-News

Interim phase 1 data evaluating MOv18 IgE, an anti-folate receptor alpha IgE antibody, in cancer patients with advanced solid tumours to be presented at...

admin - April 21, 2020 0

Latest Pharma-News

Epsilogen licences MOv18 IgE, an anti-folate receptor alpha IgE antibody from King’s College London

admin - April 21, 2020 0

Latest Pharma-News

WHO guidance helps detect iron deficiency and protect brain development

admin - April 21, 2020 0

Latest Pharma-News

Sanofi to present Phase 2 detailed results of its brain-penetrant BTK inhibitor in relapsing multiple sclerosis

admin - April 21, 2020 0

Latest Pharma-News

Novartis to study hydroxychloroquine for Covid-19

admin - April 21, 2020 0

Latest Pharma-News

New research to assess extent of coronavirus infection in children and teenagers

admin - April 21, 2020 0

Latest Pharma-News

Oxford project receives funding to assess novel coronavirus infection rates in children and teenagers across the UK.

admin - April 21, 2020 0

Latest Pharma-News

NIH to launch public-private partnership to speed COVID-19 vaccine and treatment options

admin - April 21, 2020 0

Latest Pharma-News

EMA review of Picato concludes medicine’s risks outweigh its benefits

admin - April 20, 2020 0

Latest Pharma-News

COVID-19 therapy, vaccine, epidemiology and policy development research boosted by twenty-one new projects

admin - April 20, 2020 0

Latest Pharma-News

FDA Approves First New Drug Under International Collaboration, A Treatment Option for Patients with HER2-Positive Metastatic Breast Cancer

admin - April 18, 2020 0

1...121122123...145 Page 122 of 145

Most Read

Novartis Pluvicto™ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer

June 4, 2025

FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People

June 4, 2025

J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin

April 11, 2025

Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis

April 9, 2025

EDITOR PICKS

Job Interview Questions for Clinical Data Management 2024

August 14, 2021

CRASH COURSE ON CLINICAL DATA MANAGEMENT

November 24, 2020

Interview Questions on Institutional Review Board(IRB)

August 27, 2020

POPULAR POSTS

How to Find Paid Clinical Trials Near You

January 2, 2023

What Is CDISC and What Are CDISC Data Standards?

May 17, 2022

What is Dechallenge, Rechallenge and Prechallenge in Clinical trials?

August 5, 2021

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved